are also among other researchers who developed ROR1-redirected CAR-Ts and demonstrated their antitumor activity against various solid tumor cell lines including the breast cancer cell lines MDA-MB-231 and MDA-MB-468 (178). This evidence concerns the gene ROR1 and breast carcinoma.